Literature DB >> 8275463

Isolation and identification of fresh tumor-derived endothelial cells from a murine RIF-1 fibrosarcoma.

R A Modzelewski1, P Davies, S C Watkins, R Auerbach, M J Chang, C S Johnson.   

Abstract

Tumor vasculature is anatomically heterogeneous and distinct from the vasculature found in normal mature tissues. Examination of the differences between tumor and normal vasculature is critical to the future design of therapeutic modalities which either target tumor vasculature or potentially enable more efficient delivery of tumor cytotoxic agents. Such efforts to date have been hampered due to the inability to isolate live endothelial cells from solid tumors. We report here the isolation of fresh, noncultured endothelial cells from a C3H/HeJ RIF-1 murine fibrosarcoma through the use of fluorescence-activated cell sorting based on antibody staining for angiotensin-converting enzyme with further characterization by uptake and metabolism of acetylated low-density lipoprotein, factor VIII staining, and electron microscopy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8275463

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

Review 1.  Therapeutic inhibition of angiogenesis.

Authors:  Hua-Tang Zhang; Roy Bicknell
Journal:  Mol Biotechnol       Date:  2003-10       Impact factor: 2.695

2.  Mahanine, a novel mitochondrial complex-III inhibitor induces G0/G1 arrest through redox alteration-mediated DNA damage response and regresses glioblastoma multiforme.

Authors:  Kaushik Bhattacharya; Arup K Bag; Rakshamani Tripathi; Suman K Samanta; Bikas C Pal; Chandrima Shaha; Chitra Mandal
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

3.  Leukocyte adhesion in angiogenic blood vessels. Role of E-selectin, P-selectin, and beta2 integrin in lymphotoxin-mediated leukocyte recruitment in tumor microvessels.

Authors:  P Borgström; G K Hughes; P Hansell; B A Wolitsky; P Sriramarao
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

4.  Epigenetic silencing of CYP24 in the tumor microenvironment.

Authors:  Candace S Johnson; Ivy Chung; Donald L Trump
Journal:  J Steroid Biochem Mol Biol       Date:  2010-03-19       Impact factor: 4.292

Review 5.  Angiogenesis inhibitors. New agents in cancer therapy.

Authors:  C J Ryan; G Wilding
Journal:  Drugs Aging       Date:  2000-10       Impact factor: 3.923

6.  Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo.

Authors:  Ivy Chung; Guangzhou Han; Mukund Seshadri; Bryan M Gillard; Wei-dong Yu; Barbara A Foster; Donald L Trump; Candace S Johnson
Journal:  Cancer Res       Date:  2009-01-13       Impact factor: 12.701

7.  Response of tibialis anterior tendon to a chronic exposure of stretch-shortening cycles: age effects.

Authors:  James S Ensey; Melinda S Hollander; John Z Wu; Michael L Kashon; Brent B Baker; Robert G Cutlip
Journal:  Biomed Eng Online       Date:  2009-06-29       Impact factor: 2.819

8.  Endothelin receptor in microvessels isolated from human meningiomas: quantification with radioluminography.

Authors:  S Yamaga; K Tsutsumi; M Niwa; N Kitagawa; T Anda; A Himeno; H Khalid; K Taniyama; S Shibata
Journal:  Cell Mol Neurobiol       Date:  1995-06       Impact factor: 5.046

9.  An efficient, nonenzymatic method for isolation and culture of murine aortic endothelial cells and their response to inflammatory stimuli.

Authors:  Hong Huang; Jane McIntosh; Dale G Hoyt
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Jan-Feb       Impact factor: 2.416

10.  Antagonism of Ang-Tie2 and Dll4-Notch signaling has opposing effects on tumor endothelial cell proliferation, evidenced by a new flow cytometry method.

Authors:  Marc Payton; Toni Jun; William Wayne; Dongyin Yu; Raffi Manoukian; Grace Chung; Nancy Zhang; Ji-Rong Sun; Paula Kaplan-Lefko; Sheila Scully; Gwyneth Van; Robert Radinsky; Richard Kendall; Jonathan Oliner; Angela Coxon
Journal:  Lab Invest       Date:  2014-09-22       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.